ARTICLE | Company News
FDA approves expanded Herceptin label
October 21, 2010 12:20 AM UTC
FDA approved an sBLA from Genentech Inc. for Herceptin trastuzumab to treat HER2-positive metastatic stomach cancer, including gastro-esophageal junction cancer, in combination with cisplatin plus eit...